stockrow
Friday 6 November 2026
Export GRDN’s income statement to Excel — free account
Guardian Pharmacy Services, Inc.
GRDN Healthcare Medical Care Facilities
Guardian Pharmacy Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.9% from fiscal 2024.
- Revenue
- −1.68%
- EPS
- +133.3%
- Free cash flow
- +88.9%
Quarter to September 2026, against a year earlier
39.72
2.37
−5.63%
Follow GRDN
Alert me
Guardian Pharmacy Services, Inc. (GRDN) Gross margin
Guardian Pharmacy Services, Inc.'s gross margin over the twelve months to 30 September 2026 was 22.5%, up 2.2 percentage points from fiscal 2025 (20.2%). That is below the Medical Care Facilities industry median of 30.8% and below the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 20.2% | 0.32 |
| FY2024 | 19.9% | (0.02) |
| FY2023 | 19.9% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 23.0% | 0.22 |
| Jun 2026 | 22.8% | 0.08 |
| Mar 2026 | 22.7% | 1.17 |
| Dec 2025 | 21.5% | 1.70 |
| 8 more quarters | Free account |
Gross margin against peers
| Company | Gross margin |
|---|---|
| ACHC Acadia Healthcare Company, Inc. compare | 100.0% |
| NHC National HealthCare Corporation compare | 100.0% |
| ADUS Addus HomeCare Corporation compare | 32.3% |
| AVAH Aveanna Healthcare Holdings Inc. compare | 32.3% |
| BKD Brookdale Senior Living Inc. compare | 30.8% |
| MD Pediatrix Medical Group, Inc. compare | 26.1% |
| SGRY Surgery Partners, Inc. compare | 22.5% |
| GRDN Guardian Pharmacy Services, Inc. | 22.5% |
| ASTH Astrana Health, Inc. compare | 10.5% |
| Medical Care Facilities industry median | 30.8% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on GRDN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- The full statement